Featured Content

TRIPLE YOUR MONEY IN A MONTH!

TRIPLE YOUR MONEY IN A MONTH!

Still worried about the economy? Become an elite charter member of George's DAILY PROFITS and you could... TRIPLE YOUR MONEY IN A MONTH! George gave us the $2.8-billion IT infrastructure provider, up 4,745.20%; the $1.8-billion advertising agency, up 1,295.44%; and the $762 million business software company, up 1,213.19%. Only charter members can follow George daily. Learn how here!

Earnings Picture Starts off Bright with Oracle

By

Earnings Picture Starts off BrightYou know the stock market is stuck in a rut when it doesn’t react to news, either good or bad. That’s the market we have now: directionless trading with no real expectation of a trend. Part of the current stock market malaise has to do with political negotiations regarding the fiscal cliff and the uncertainty this creates. Any final agreement on the issue should help the stock market; this can’t happen soon enough.

The Dow Jones Transportation Index (or average) has been surprisingly strong over the last several weeks. The bounceback was likely due to a combination of factors, including a technical rebound among many components and lower diesel prices. This index has been a real laggard in the stock market, and it really has to break 5,400 to signal any lasting bullish sentiment.

Corporate earnings from Oracle Corporation (NASDAQ/ORCL) were good, and it’s a sign that enterprises are spending on information technology to improve productivity. There’s been a lot of uneven share price action among large-cap technology stocks. Enterprise-level technology companies are outperforming more consumer-oriented businesses, and this highlights the reticence consumers have to spend. There’s also a technology migration taking place, and it’s away from the personal computer (PC) and Microsoft Corporation’s (NASDAQ/MSFT) “Windows” operating system.

Oracle’s stock market chart is below:

ORCL Oracle Crop, Nasdaq stock market chart

Chart courtesy of www.StockCharts.com

One of the strongest indices over the last 12 months has been the NASDAQ Biotechnology Index. Many biotechnology stocks have been the market’s best performers this year. Not too long ago, we looked at Alexion Pharmaceuticals, Inc. (NASDAQ/ALXN) in this column. . (See “It’s a Traders’ Market with Only a Few Stocks Doing Great.”) This stock experienced a well-deserved price correction after going up for two years straight. It is in a tentative recovery now, and the company’s earnings estimates keep going up. Alexion is a liquid biotechnology stock that’s good for traders. The company’s stock market chart is featured below:

ALXN Alexion Pharmaceuticals, Nasdaq stock market chart

Chart courtesy of www.StockCharts.com

I’m becoming a little more bullish on corporate earnings as the year comes to an end. If we get strong earnings growth from technology and financial stocks, then the stock market is going to materially advance. There is an economic recovery at hand, and the latest gross domestic product (GDP) numbers on the U.S. economy were surprisingly good. The key, I would say, is for this recovery not to get messed up by some outside shock. Regardless of the numbers, however, investor sentiment is taking a hit in the absence of a solid deal on the fiscal cliff.

As a group, the financials report their quarterly earnings very soon in the New Year, and as always, they will set the tone for the rest of the earnings season. Another quarter of revenue weakness is likely, with big multinationals operating in Europe and China. The best prospects for earnings growth should be from companies with large domestic operations. Earnings from railroad stocks will also be an important indicator.

Premium Content

Secret "New Swiss Bank Account" Safest Way to 44% Returns

Secret

It's the safest—but, until now, completely ignored—place for your money. Because these elite "bank accounts" pay guaranteed 5% cash payments per annum on top of returns on capital exceeding 44%... Learn all about them here.

About the Author, Browse Mitchell Clark's Articles

Mitchell Clark is a senior editor at Lombardi Financial, specializing in large- and micro-cap stocks. He’s the editor of a variety of popular Lombardi Financial newsletters, including Micro-Cap Reporter, Income for Life, Biotech Breakthrough Stock Report, and 100% Letter. Mitchell has been with Lombardi Financial for 17 years. He won the Jack Madden Prize in economic history and is a long-time student of equity markets. Prior to joining Lombardi, Mitchell was a stockbroker for a large investment bank. In the... Read Full Bio »

Exclusive profit Confidential Presentation

Secret Retirement Plan Pays Up to $12,160 a Month?

Secret Retirement Plan Pays Up to $12,160 a Month?

A select group of Americans are retiring with a little-known retirement plan whose advertisement by its issuers is censored by Congress... Yet this plan enables Americans to potentially collect up to $12,160 in monthly income that's sponsored entirely by large-cap American companies. These secret Sponsored Retirement Plans are trumping social security by up to 10 times. And unlike mainstream retirement plans like 401(k)s or IRAs, SRPs are ideal for people who want to start with very little money. You could begin your SRP with as little as $10, $50, $100 or $400. To see real-life stories of folks who've built hundred-thousand-dollar portfolios thanks to SRPs and how to get your own plan started today, click here now!

×